Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
about
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaEGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaIDH1 and IDH2 mutations in gliomasRecent advances in the molecular understanding of glioblastomaMolecular characterizations of glioblastoma, targeted therapy, and clinical results to dateO(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsEpigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumorsRecent advancements in multimodality treatment of gliomasNovel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1Glioblastoma genetics: in rapid flux.The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature reviewMolecular heterogeneity in glioblastoma: potential clinical implicationsMolecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationPrognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaChromosome 7p11.2 (EGFR) variation influences glioma riskPredicting survival in head and neck squamous cell carcinoma from TP53 mutation.Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testingTreatment of glioblastoma in elderly patients.BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.Restoration of sensitivity in chemo-resistant glioma cells by cold atmospheric plasma.Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patientsIDH mutations: genotype-phenotype correlation and prognostic impact.Prognostic value of blood flow measurements using arterial spin labeling in gliomasGlioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and scienceAnalysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasGliomas in adults.A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.Visualizing molecular profiles of glioblastoma with GBM-BioDP.1p/19q testing has no significance in the workup of glioblastomas.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesThe combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.Glioblastoma biomarkers from bench to bedside: advances and challenges.A radiosensitivity gene signature in predicting glioma prognostic via EMT pathwayDefective p53 antiangiogenic signaling in glioblastoma.Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from ChinaBiology, genetics and imaging of glial cell tumours
P2860
Q21261286-10C77366-4DFE-4011-A795-B61C9AC7FF63Q24338526-7E2094B1-A483-4D69-A6F1-FCFDDB18AD57Q24561928-0368808A-53B4-46CB-AE01-7740CEF78DCAQ24632928-74B762B4-6111-4CA5-97FB-FF5AA74164CBQ26822717-2C87D2EF-9C23-40C9-8903-9F9A69CFCF98Q26853112-47D68FD1-7663-4B69-9F47-193526337247Q26864920-E0E3E387-79CC-4D6B-ABAE-BADAAA3D6B45Q27001724-910AB449-63CC-467E-8704-2638A3145C27Q27687464-1D7CE100-0A39-4CEB-9D38-5E1A400E6E81Q27691826-D64BD2F4-6C36-42DD-9BC4-13183A9DE468Q27851550-E9264425-66F8-4FFD-BB63-9C5BC534C29FQ28069940-E69D58EF-DDEC-4C88-BEF2-3E12890F5099Q28088605-B1AFD207-3B9D-4EC1-B3D5-8911CD966339Q28383205-80B7B54B-D558-4738-92CD-BF085B21280AQ28731328-639C9387-0027-4EED-B519-524566AFD3A8Q28943530-24B38F44-C1A5-4E8C-906F-28D179581EB2Q30365539-F982ED92-933E-48C7-AC93-BAB7F7C82496Q30810936-EC686608-9AC7-4C10-A07E-2F342D1C7B1BQ30838145-777EC105-5486-4540-A39D-FBF756821413Q31002780-866233DB-7184-4FE7-9EFA-F970DEC556A9Q31016728-32886F00-2908-4B15-86ED-E60A2C9EF7B6Q31118089-E4233E69-562F-44E3-AD23-E0DF91FE86A6Q33591658-2020C45F-889D-4634-BBCE-67ADCE242469Q33597773-709EFAEB-DAC5-4A0B-928B-23193A456B87Q33615867-6783617D-45D4-4BEE-83F3-12EFC7EA22ACQ33727772-17579032-238B-4279-9F85-60BC909E377BQ33746514-AF1529CC-3F4B-44DB-9126-090A9B73FD44Q33753426-40524F9F-7185-450D-8E2E-2E4DA2B31026Q33760539-5936BA3D-3E84-4961-9888-C6280CEB3421Q33784612-1726D713-953D-443F-A8DB-FF9813C6930AQ33881602-E7D9109E-E65D-4D0E-A7C5-0ADCEF9B9816Q33893445-BBBDC5DB-219B-4CDA-A054-BDE0EF1EFBC5Q33925544-7ABDD870-3E15-4710-9EF2-921BDA37DC85Q34061985-A3C3AE76-429F-4B30-9EDF-D7421EFCC690Q34103890-929A0FBB-16BB-4EB8-83FD-0A39F126AF28Q34103984-91594770-582B-4C6D-B90C-96A2F44F00BCQ34133118-C1045E3A-A041-48C7-9D14-03D8C9983A7CQ34135404-0AABFF42-07E3-4706-BB1F-9E5541119162Q34146009-A888ADBB-173F-4DAC-ACEC-F8EB9B9A9BA6Q34203979-F320FFFE-D2BA-4532-92D4-A27F9AC45C3B
P2860
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Molecular predictors of progre ...... of the German Glioma Network.
@en
Molecular predictors of progre ...... of the German Glioma Network.
@nl
type
label
Molecular predictors of progre ...... of the German Glioma Network.
@en
Molecular predictors of progre ...... of the German Glioma Network.
@nl
prefLabel
Molecular predictors of progre ...... of the German Glioma Network.
@en
Molecular predictors of progre ...... of the German Glioma Network.
@nl
P2093
P50
P356
P1476
Molecular predictors of progre ...... of the German Glioma Network.
@en
P2093
Christian Hartmann
Dietmar Krex
Gabriele Schackert
Guido Nikkhah
Hilmar Berger
Joachim P Steinbach
Johannes Schramm
Jörg C Tonn
Manfred Westphal
Markus Loeffler
P304
P356
10.1200/JCO.2009.23.0805
P407
P577
2009-10-05T00:00:00Z